ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,328Medicare Part D Prescriptions Filled, Including Refills

Rank: 35 out of 444

$392K Total Retail Price of All Prescriptions

Rank: 99 out of 444

979 Patients Receiving at Least One Drug in Part D
87% Patients 65 Years and Older
15% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in Nevada
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

7% of this provider’s 979 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

15% of this provider’s 979 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Brand Name Drugs

16% of this provider’s prescriptions were for brand-name drugs, compared to an average of 19%.

Prescription Price

$32 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

13 is the average number of prescriptions (including refills) per patient, compared to an average of 13.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in Nevada
LEVOTHYROXINE SODIUM 704 642 154 1 2
LISINOPRIL 647 600 170 2 1
SIMVASTATIN 603 557 155 3 3
OMEPRAZOLE 596 519 163 4 5
HYDROCODONE-ACETAMINOPHEN 500 444 136 S3 5 4
AMLODIPINE BESYLATE 476 436 121 6 6
ATENOLOL 344 303 76 7 17
ATORVASTATIN CALCIUM 314 279 76 8 8
LOSARTAN POTASSIUM 290 267 69 9 9
HYDROCHLOROTHIAZIDE 251 212 72 10 10
METFORMIN HCL 243 228 57 11 7
GABAPENTIN 229 207 68 12 11
ALENDRONATE SODIUM 215 210* 71 13 18
WARFARIN SODIUM 198 187 35 14 22
METOPROLOL TARTRATE 193 177 46 15 14
METOPROLOL SUCCINATE 169 135 34 16 20
LOVASTATIN 168 163* 46 17 15
RANITIDINE HCL 164 147 45 18 36
ALPRAZOLAM 163 149 51 B 19 13
FUROSEMIDE 147 147 36 20 12
PRAVASTATIN SODIUM 133 116 34 21 16
CLOPIDOGREL 131 117 35 22 24
VENTOLIN HFA 130 125* 52 23 34
ZOLPIDEM TARTRATE 126 96 29 24 19
LISINOPRIL-HYDROCHLOROTHIAZIDE 120 115* 35 25 23
ALLOPURINOL 119 119 29 26 30
FLUTICASONE PROPIONATE 119 114* 60 26 27
CITALOPRAM HBR 108 103* 33 28 25
LOSARTAN-HYDROCHLOROTHIAZIDE 107 102* 26 29 35
TERAZOSIN HCL 106 106 24 30 46
GLIPIZIDE 103 98* 22 31 33
CARVEDILOL 99 94* 25 32 26
OXYBUTYNIN CHLORIDE 98 93* 18 33 82
POTASSIUM CHLORIDE 98 98 28 33 21
SYMBICORT 84 84 20 35 98
ENALAPRIL MALEATE 80 80 18 36 74
DILTIAZEM ER 78 67 13 37 118
SERTRALINE HCL 77 72* 20 38 31
FENOFIBRATE* 75 70* 16 39 50
METFORMIN HCL ER 72 57 22 40 52
TRIAMTERENE-HCTZ 70 65* 23 41 54
GLIPIZIDE ER 69 64* 22 42 61
DONEPEZIL HCL 63 63 18 43 38
FLUOXETINE HCL 63 47 16 43 39
TAMSULOSIN HCL 63 63 15 43 29
PANTOPRAZOLE SODIUM 62 48 16 46 44
ESTRADIOL 61 61 11 R 47 89
PAROXETINE HCL 60 37 14 48 65
GLIMEPIRIDE 58 58 14 49 51
LORAZEPAM 57 52* 15 B 50 48
CLONIDINE HCL 55 55 12 51 67
BENAZEPRIL HCL 54 54 13 52 60
NIFEDIPINE ER 52 52 18 53 85
CIPROFLOXACIN HCL 52 47* 42 53 56
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 14, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.